Michael Schultz

Michael Schultz

Company: Viewpoint Molecular Targeting

Job title: Chief Science Officer

Seminars:

Chelation And Linker Chemistry For Pb- 203/Pb-212 Alpha-Particle Peptide Based Radiopharmaceutical Therapies For Cancer 2:00 pm

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.